Glenview Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-26,902
Closed -$2.67M 357
2019
Q3
$2.67M Buy
26,902
+3,544
+15% +$337K 0.16% 117
2019
Q2
$2.16M Sell
23,358
-6,627
-22% -$629K 0.13% 123
2019
Q1
$2.83M Sell
29,985
-46,991
-61% -$4.11M 0.18% 115
2018
Q4
$4.93M Sell
76,976
-31,984
-29% -$2.36M 0.36% 81
2018
Q3
$9.75M Buy
108,960
+9,813
+10% +$867K 0.61% 48
2018
Q2
$7.87M Sell
99,147
-1,666
-2% -$138K 0.59% 53
2018
Q1
$8.99M Buy
100,813
+7,428
+8% +$713K 0.62% 49
2017
Q4
$9.75M Buy
93,385
+19,669
+27% +$2.22M 0.67% 47
2017
Q3
$10.8M Buy
73,716
+1,436
+2% +$196K 0.79% 38
2017
Q2
$9.39M Buy
72,280
+1,796
+3% +$220K 0.73% 47
2017
Q1
$8.77M Buy
70,484
+3,628
+5% +$434K 0.69% 48
2016
Q4
$7.74M Buy
+66,856
New +$7.45M 0.64% 54
2015
Q4
$2.88M Buy
+24,048
New +$2.78M 0.3% 87
2014
Q4
$1.13M Buy
+10,121
New +$1.07M 0.12% 106
2013
Q4
$516K Buy
+6,108
New +$483K 0.06% 136

Other funds holding CELG

Glenview Trust's CELG Position: Q4 2019 in Review

Glenview Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 26,902 shares — an estimated $2.67M sold.

Glenview Trust first reported a position in CELG in Q4 2013 and held it in 15 quarters. The position peaked at $10.8M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Glenview Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Glenview Trust sold 26,902 Celgene Corp shares in Q4 2019, an estimated $2.67M.
  • Glenview Trust first reported a position in Celgene Corp in Q4 2013 and held it in 15 quarters.
  • Glenview Trust's Celgene Corp position peaked at $10.8M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Glenview Trust's 13F filing for Q4 2019, filed 6 Feb 2020.